CV Sciences, Inc. (OTCMKTS:CVSI) Shares Shorted: Short Interest Up 123.1% in SeptemberDefense World · Oct 13, 2026
CV Sciences Welcomes Enactment of Federal Legislation Providing Additional Time for a Responsible, Science-Based Hemp Regulatory FrameworkAccesswire · Sep 8, 2026
CV Sciences (OTCMKTS:CVSI) Shares Cross Below 50 Day Moving Average – What’s Next?Defense World · Sep 3, 2026
CV Sciences, Inc. (CVSI) Q2 2026 Earnings Call TranscriptSeeking Alpha · Aug 13, 2026
CV Sciences, Inc. Reports Second Quarter-End 2026 Financial ResultsAccesswire · Aug 13, 2026
CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond CannabinoidsAccesswire · Aug 11, 2026CV Sciences, Inc. functions as a life sciences organization primarily operating across North America. Its business activities are organized into two distinct divisions: Consumer Products and Specialty Pharmaceutical. The Consumer Products division focuses on the creation, manufacturing, and commercialization of plant-derived dietary supplements and cannabidiol (CBD) products sourced from hemp.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 13, 2026 | -$0.02 | -$0.00 | Beat |
| May 14, 2026 | -$0.02 | -$0.00 | Beat |
| Mar 26, 2026 | -$0.01 | -$0.00 | Beat |
| Nov 13, 2025 | – | -$0.00 | |
| Aug 13, 2025 | – | -$0.00 | |
| May 14, 2025 | – | -$0.00 |